Why is Hester Bios falling/rising?

As of 12-Sep, Hester Biosciences Ltd's stock price is currently at 2,072.00, reflecting a decrease of 39.0 points or 1.85%. The stock has underperformed its sector today by 2.14% and has experienced a trend reversal after two consecutive days of gains. Over the past week, the stock has declined by 2.51%, while it has shown a modest increase of 6.97% over the past month. Despite positive financial results, including a 145.1% growth in net profit and consistent positive results for the last five quarters, the stock faces challenges such as a high Debt to EBITDA ratio of 3.49 times and poor long-term growth rates, which may contribute to its recent price decline.
In the broader market context, the Sensex has increased by 1.48% over the past week, contrasting with Hester Biosciences' decline. This underperformance against the benchmark is consistent with the company's trend of generating negative returns over the past year, where it has seen a decrease of 12.05%. The lack of domestic mutual fund investment, which stands at 0%, may indicate a lack of confidence in the stock's valuation, despite its trading at a discount compared to peers. Overall, the combination of high debt levels, low profitability, and consistent underperformance against the market appears to be driving the stock's recent decline.